The 2026 GLP-1 Long-Term Strategy Playbook: Beyond Access, Toward Lasting Outcomes Key Takeaways In order to serve members and address costs, GLP-1 strategies must expand beyond access and affordability to also focus on lasting outcomes and value
But consider the cost of: Ongoing health conditions related to excess weight Medications for blood pressure, cholesterol, or diabetes Lost productivity and quality of life Previous diet programs that didnt work For many patients, Semaglutide pays for itself in reduced healthcare costs and improved wellbeing
The other thing is, at least from the basic research viewpoint, there are tumors that express GLP-1 receptors, particularly pancreatic neuroendocrine tumors and duodenal neuroendocrine tumors, where there's the potential of having growth
Heres the skinny on this popular drug being touted for its long-term success when it comes to weight management
You must be over 38, have had your ovaries removed or have suffered with premature menopause to warrant further hormone tests
Unlike some medications that require careful scheduling to avoid interactions, these two treatments can theoretically be administered on the same day without compromising safety or efficacy